Smallpox

Rare Disease·MeSH: Smallpox

11 drugs in development·6 companies·3 clinical trials

Drug Pipeline by Phase

Approved(5)

Drug	Company
acam2000	Emergent BioSolutions Inc. (EBS)
iv tpoxx	SIGA TECHNOLOGIES INC (SIGA)
tembexa	Emergent BioSolutions Inc. (EBS)
tpoxx	SIGA TECHNOLOGIES INC (SIGA)
vigiv cnj-016	Emergent BioSolutions Inc. (EBS)

Phase 3(1)

Drug	Company
geo-mva	GeoVax Labs, Inc. (GOVX)

Phase 2(3)

Drug	Company
nv-387	NANOVIRICIDES, INC. (NNVC)
smallpox	SIGA TECHNOLOGIES INC (SIGA)
Tecovirimat	UNITED THERAPEUTICS Corp (UTHR)

Unknown(1)

Drug	Company
vigiv	Emergent BioSolutions Inc. (EBS)

Phase 4(1)

Drug	Company
mRNA-1769	Moderna, Inc. (MRNA)

BioSniper tracks 11 drugs in development for Smallpox across 6 companies.

There are 3 clinical trials targeting Smallpox tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.